Promising Test Results Leads to Design Improvements

IRVINE, CA / ACCESSWIRE / December 16, 2020 / Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life-saving medical products, is pleased to provide the following update on the development of its Save A Life choking rescue device. Product development and design partner Tanaka Kapec Design Group (TKDG) has continued to advance the product development with the ultimate goal of filing a submission to the FDA for the life-saving choking rescue device.

TKDG has identified, researched, designed and tested the suction interface tip that allows for effective removal of the lodged mass.. The improved design relates to the aperture diameter and aperture shape and has been optimized for the product. TKDG conducted testing with principal food items that are often a cause for choking. Additionally, testing focused on tips in conjunction with the pump and negative pressure with various food items. Such recommendations have led to to improved ergonomics, increased power with high efficiency and ease of use.

Odyssey Chairman and Chief Executive Officer Michael Redmond, commented, "We continue to advance the development of our Save A Life choking rescue device with our eyes on an FDA submission by the end of 2021, assuming we have access to the capital needed. The work by TKDG and its discovery was productive related to relationships between aperture size at tip, pressure and food size. Preliminary results are promising, and we look forward to continuing our work with TKDG."

About Odyssey Group International, Inc.

Odyssey Group International, Inc. (OTCQB:ODYY) is a technology and asset acquisition company with a focus in the area of life saving medical solutions. Odyssey's corporate mission is to create, acquire and accumulate distinct assets, intellectual properties, and exceptional technologies that provide meaningful medical solutions The Company is focused on building and acquiring assets in areas that have an identified technological advantage, provide superior clinical utility, have a substantial market opportunity and provide solid returns to its valued shareholders and partners.

For more information, visit:

Forward-Looking Statements

This news release may contain forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including economic slowdown affecting companies, our ability to successfully develop products, rapid change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions.

Media and Investors Contacts:



SOURCE: Odyssey Group International, Inc.

View source version on